🖼

Fig. 2 — RNA splicing and splicing regulator changes in prostate cancer pathology.

active
paper figure Created: 2026-04-21T18:29:40 By: paper_figures_tool Quality: 50% 🔗 External ID: paper-fig-paper-6ec76a6d668d-2
Fig. 2 — RNA splicing and splicing regulator changes in prostate cancer pathology.
Fig. 2Figure 2
Prostate tissue visualised using tissue biopsies. a , b . Histological sections made from benign prostatic hyperplasia (BPH, with normal glandular structure embedded in stroma). Prostate cancer development is clinically described as a series of Gleason grades (1–5, with 1 corresponding to well-differentiated tissue containing a glandular structure and 5 being the most advanced with only few glands still visible) (Gleason and Mellinger 1974 ; Mellinger et al. 1967 ). c , d Histological sections made from prostate cancer (Gleason grade 5, notice breakdown of glandular structure). Left panels, sections processed using H&E staining. Right panels, sections processed by staining with haematoxylin and counterstaining with the RNA-binding protein Sam68 ( brown stain ). Figure adapted from (Rajan et al. 2008 ) with permission from the Journal of Pathology
PubMed: paper-6ec76a6d668d
Metadata
pmidpaper-6ec76a6d668d
captionProstate tissue visualised using tissue biopsies. a , b . Histological sections made from benign prostatic hyperplasia (BPH, with normal glandular structure embedded in stroma). Prostate cancer deve
image_urlhttps://www.ebi.ac.uk/europepmc/articles/PMC5602090/bin/439_2017_1792_Fig2_HTML.jpg
paper_titleRNA splicing and splicing regulator changes in prostate cancer pathology.
figure_labelFig. 2
figure_number2
_schema_version1
source_strategypmc_api
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.